The effect of provenance and species on the chemical composition of Epilobium herbal tea.

BACKGROUND

Commercial herbal teas marketed as Epilobium herb are widely consumed in Europe for prostate-related and anti-inflammatory effects. However, they are often sold under generic names without clear species differentiation or quality specifications, raising concerns about chemical consistency and therapeutic equivalence.

OBJECTIVE

To evaluate the chemical equivalence of commercial Epilobium products and refine the framework for quality marker selection by integrating pharmacological relevance with structural assessment.

MATERIALS AND

METHODS

Sixteen commercial tea samples labeled as E. angustifolium, E. parviflorum, E. hirsutum, from eight European countries were analyzed using high-performance thin-layer chromatography (HPTLC) and validated by HPLC-DAD. Candidate markers were prioritized using the Herbal Chemical Marker Ranking System (Herb MaRS) and further assessed via Pan-Assay Interference Compounds (PAINS) structural filters.

RESULTS

Significant qualitative and quantitative heterogeneity was observed across all samples, including those labeled as the same species. Oenothein B was the dominant compound but exhibited high variability (7.9-48.7 mg/g DW; CV >50%) and was significantly higher in E. hirsutum (p < 0.05). Flavonol glycosides (e.g., hyperoside, isoquercitrin) also varied substantially. Although species identity influenced phenolic profiles, overlapping concentration ranges indicated a lack of chemical equivalence among products. Geographic origin contributed additional but secondary variability.

DISCUSSION: Oenothein B, hyperoside, and isoquercitrin were identified as priority quality markers based on abundance and analytical suitability. Structural reassessment demonstrated that pharmacological ranking alone may be misleading for polyphenol-rich matrices due to redox-related interference.

CONCLUSION

Commercial Epilobium teas differ chemically and are not interchangeable. A structure-informed approach is essential for reliable quality assessment and for aligning commercial products with pharmacopeial standards.